Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
Lipoatrophy, the loss of body fat from particular areas of the body, is a common side effect
of antiretroviral therapy (ART). The purpose of this study was to determine the effectiveness
of uridine supplementation in treating HIV infected individuals on stable ART with
lipoatrophy.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)